By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GlaxoSmithKline has teamed with the European Bioinformatics Institute (EMBL-EBI), the US National Library of Medicine, and informatics provider Collaborative Drug Discovery to freely share the chemical structures of 13,500 molecules from GSK's compound library for malaria research. EMBL-EBI will serve as the primary repository for the data on the compound set.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.